Welcome AAMDS, a New Patient Worthy Advocacy Partner!

We're happy to introduce a new partner to Patient Worthy's mission of advocating for rare disease patients! The Aplastic Anemia and MDS International Foundation (AAMDS) supports, connects and educates patients, caregivers…

Continue Reading Welcome AAMDS, a New Patient Worthy Advocacy Partner!
A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes
Source: Pixabay

A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes

A press release from Aprea Theraputics has just announced the results of a Phase II clinical trial of the drug APR-246 in patients with myelodysplastic syndromes (a group of blood…

Continue Reading A Treatment Trial Has Produced Promising Results in Patients With Myelodysplastic Syndromes
This Drug May Reduce Your Dependence on Transfusions
Source: https://pixabay.com/en/blood-medical-attempts-tube-1291132/

This Drug May Reduce Your Dependence on Transfusions

Celgene Corporation, partnered with Acceleron Pharma Inc., announced at the beginning of this month that target enrollment of myelodysplastic syndromes (MDS) and beta thalassemia patients for the MEDALIST and BELIEVE…

Continue Reading This Drug May Reduce Your Dependence on Transfusions

Editor’s Choice: Events on Events on Events! Help Raise Sjogren’s Awareness and BOS Awareness

Happy Friday Patient Worthians! April is Sjogren's Awareness Month! There was also a whole day dedicated to Bohring-Opitz Syndrome. The MDS Foundation has another upcoming event as well. Lastly, last month…

Continue Reading Editor’s Choice: Events on Events on Events! Help Raise Sjogren’s Awareness and BOS Awareness